Brevibloc and Ventricular fibrillation - a phase IV clinical study of FDA data

Summary:

Ventricular fibrillation is reported as a side effect among people who take Brevibloc (esmolol hydrochloride), especially for people who are male, 20-29 old, have been taking the drug for < 1 month also take Nexterone, and have Arrhythmias.

The phase IV clinical study analyzes which people have Ventricular fibrillation when taking Brevibloc. It is created by eHealthMe based on reports of 259 people who have side effects when taking Brevibloc from the FDA, and is updated regularly.

What is Brevibloc?

Brevibloc has active ingredients of esmolol hydrochloride. eHealthMe is studying from 259 Brevibloc users. Check the latest studies of Brevibloc.

What is Ventricular fibrillation?

Ventricular fibrillation (abnormally irregular heart rhythm) is found to be associated with 1,099 drugs and 1,245 conditions by eHealthMe. Check the latest studies of Ventricular fibrillation.

On Jul, 04, 2026

259 people reported to have side effects when taking Brevibloc.
Among them, 12 people (4.63%) have Ventricular fibrillation.

Could Brevibloc cause Ventricular fibrillation?

Among these 12 people:

How long have people been on Brevibloc when they have Ventricular fibrillation? *

What is the gender of people who have Ventricular fibrillation when taking Brevibloc? *

female: 0.0 %
male: 100 %

What is the age of people who have Ventricular fibrillation when taking Brevibloc? *

What are other drugs people take besides Brevibloc? *

What are other side effects people have besides Ventricular fibrillation? *

Bradycardia (abnormally slow heart action): 5 people, 41.67%
Cardiac Arrest: 4 people, 33.33%
Cranial Nerve Disorder (impaired functioning of one of the twelve cranial nerves): 3 people, 25.00%
Delayed Recovery From Anaesthesia: 3 people, 25.00%
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin): 3 people, 25.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 3 people, 25.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 25.00%
Mental Impairment (a condition affecting the body, perhaps through sight or hearing loss, a mobility difficulty or a health condition): 3 people, 25.00%
Hypotension (abnormally low blood pressure): 2 people, 16.67%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 2 people, 16.67%

What are the existing conditions these people have? *

Arrhythmias (irregular heartbeat): 4 people, 33.33%
Anaesthesia: 3 people, 25.00%
Ventricular Tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart): 1 person, 8.33%
Renal Impairment (severely reduced kidney function): 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%
High Blood Pressure: 1 person, 8.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%
Chest Pain: 1 person, 8.33%
Cardiogenic Shock (inadequate circulation of blood): 1 person, 8.33%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Brevibloc and have Ventricular fibrillation?

- Check whether Ventricular fibrillation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Brevibloc:

Brevibloc (259 reports)

Browse all side effects of Brevibloc:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,099 drugs)

Browse all the conditions that are associated with Ventricular fibrillation:

Ventricular fibrillation (1,245 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on esmolol hydrochloride (the active ingredients of Brevibloc) and Brevibloc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.